Literature DB >> 21261645

Chemopreventive effects of resveratrol and resveratrol derivatives.

Thomas Szekeres1, Philipp Saiko, Monika Fritzer-Szekeres, Bob Djavan, Walter Jäger.   

Abstract

Resveratrol is considered to have a number of beneficial effects. Recently, our group modified the molecule and synthesized a number of compounds with different biochemical effects. Polymethoxy and polyhydroxy derivatives of resveratrol were shown to inhibit tumor cell growth in various cell lines and inflammation pathways (cyclooxygenases activity), in part more effectively than resveratrol itself. One lead compound (hexahydroxystilbene, M8) turned out to be the most effective inhibitor of tumor cell growth and of cyclooxygenase 2 activity. M8 was then studied in two different human melanoma mouse models. This novel resveratrol analog was able to inhibit melanoma tumors in a primary tumor model alone and in combination with dacarbacine, an anticancer compound that is used for melanoma treatment. We also tested the development of lymph node metastasis in a second melanoma model and again M8 successfully inhibited the tumor as well as the size and weight of lymph node metastasis. Hydroxylated resveratrol analogs therefore represent a novel class of anticancer compounds and promising candidates for in vivo studies.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21261645     DOI: 10.1111/j.1749-6632.2010.05864.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  39 in total

Review 1.  Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.

Authors:  Giovanna Giovinazzo; Ilaria Ingrosso; Annalisa Paradiso; Laura De Gara; Angelo Santino
Journal:  Plant Foods Hum Nutr       Date:  2012-09       Impact factor: 3.921

2.  Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes.

Authors:  Monireh Hedayati; Nayereh Shafaghati; Seyed Jalal Hosseinimehr
Journal:  Radiat Environ Biophys       Date:  2013-02-23       Impact factor: 1.925

3.  Piceatannol protects against cisplatin nephrotoxicity via activation of Nrf2/HO-1 pathway and hindering NF-κB inflammatory cascade.

Authors:  Sara A Wahdan; Samar S Azab; Doaa A Elsherbiny; Ebtehal El-Demerdash
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-14       Impact factor: 3.000

Review 4.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

5.  Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.

Authors:  Ibrahim Altamemi; E Angela Murphy; James F Catroppo; Elizabeth E Zumbrun; Jiajia Zhang; Jamie L McClellan; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

Review 6.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

Review 7.  Polyphenol compounds and PKC signaling.

Authors:  Joydip Das; Rashmi Ramani; M Olufemi Suraju
Journal:  Biochim Biophys Acta       Date:  2016-06-29

8.  An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.

Authors:  Seung Hun Jeong; In Sung Song; Hyoung Kyu Kim; Sung Ryul Lee; Suhee Song; Hongsuk Suh; Young Geol Yoon; Young Hyun Yoo; Nari Kim; Byoung Doo Rhee; Kyung Soo Ko; Jin Han
Journal:  Mol Cells       Date:  2012-10-18       Impact factor: 5.034

9.  Resveratrol (3,5,4'-trihydroxystilbene) and its properties in oral diseases.

Authors:  Donatella Perrone; Maria Pia Fuggetta; Fatima Ardito; Andrea Cottarelli; Anna De Filippis; Giampietro Ravagnan; Salvatore De Maria; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2017-05-18       Impact factor: 2.447

10.  Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.

Authors:  Jamie Josephine Avila McLeod; Heather L Caslin; Andrew J Spence; Elizabeth M Kolawole; Amina Abdul Qayum; Anuya Paranjape; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Howard L Elford; John J Ryan
Journal:  Cell Immunol       Date:  2017-09-21       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.